Refereed Journal Articles

  1. Addis, S., Sherwood, D., Mace, W., Mancuso, S. G., Koloth, R., & Castle, D. J. (2012). A naturalistic study of pharmacological management of behavioural disturbance in psychosis. Journal of Psychiatric Intensive Care, 8(2), 120-125.
  2. Bahar-Fuchs, A., Marques, D. M., Mancuso, S., Cong, Z., Hampstead, B. M., Belleville, S., . . . Goodenough, B. (2018). Cognition-oriented Treatments Article Library and Evaluation (CogTALE): A novel online platform for cognitive intervention research evaluation, synthesis, and translation.. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 14(7), P1359-P1360.
  3. Bosanac, P., Hamilton, B., Beatson, J., Trett, R., Rao, S., Mancuso, S., & Castle, D. (2015). Mentalization-based intervention to recurrent acute presentations and self-harm in a community mental health service setting. Australasian Psychiatry, 23(3), 277-281.
  4. Bosanac, P., Mancuso, S. G., & Castle, D. (2013). Anxiety symptoms in psychotic disorders: results from the Second Australian National Mental Health Survey. Clinical Schizophrenia & Related Psychoses, 1-22.
  5. Bousman, C., Luza, S., Mancuso, S., Kang, D., Mostaid, M. S., Cropley, V., . . . Bush, A. (2019). Ubiquitinated proteins are elevated in the blood and brains of individuals with schizophrenia. European Neuropsychopharmacology, 29, S945.
  6. Bousman, C. A., Arandjelovic, K., Mancuso, S. G., Eyre, H. A., & Dunlop, B. W. (2019). Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics, 20(01), 37-47.
  7. Bousman, C. A., Luza, S., Mancuso, S. G., Kang, D., Opazo, C. M., Mostaid, M. S., . . . Pantelis, C. (2019). Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia. Scientific Reports, 9(1), 1-8.
  8. Caudle, H., Pang, C., Mancuso, S., Castle, D., & Newton, R. (2015). A retrospective study of the impact of DSM-5 on the diagnosis of eating disorders in Victoria, Australia. Journal of Eating Disorders, 3(1), 35.
  9. Cooper, J., Mancuso, S. G., Borland, R., Slade, T., Galletly, C., & Castle, D. (2012). Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis. Australian & New Zealand Journal of Psychiatry, 46(9), 851-863.
  10. Ferdowsi, N., Huq, M., Stevens, W., Hudson, M., Wang, M., Tay, T., . . . Sundararajan, V. (2019). Development and validation of the scleroderma clinical Trials Consortium damage index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis. Annals of the Rheumatic Diseases, 78(6), 807-816.
  11. Grant, M., Ugalde, A., Mancuso, S. G., Vafiadis, P., & Philip, J. (2017). Morphine use in cancer care: A survey of attitudes and perceptions in general practice patients. Australian Family Physician, 46(10), 775.
  12. Hocking, D. C., Mancuso, S. G., & Sundram, S. (2018). Development and validation of a mental health screening tool for asylum-seekers and refugees: the STAR-MH. BMC Psychiatry, 18(1), 69.
  13. Hoffmann, C., Van Rheenen, T. E., Mancuso, S. G., Zalesky, A., Bruggemann, J., Lenroot, R. K., . . . Pantelis, C. (2018). Exploring the moderating effects of dopaminergic polymorphisms and childhood adversity on brain morphology in schizophrenia-spectrum disorders. Psychiatry Research: Neuroimaging, 281, 61-68.
  14. Knoesen, N. P., Mancuso, S. G., Thomas, S., Komesaroff, P., Lewis, S., & Castle, D. J. (2012). Relationship between severity of obesity and mental health: An Australian community survey. Asia‐Pacific Psychiatry, 4(1), 67-75.
  15. Liu, C., Kanazawa, T., Tian, Y., Saini, S. M., Mancuso, S., Mostaid, M. S., . . . Yu, H. (2019). The schizophrenia genetics knowledgebase: a comprehensive update of findings from candidate gene studies. Translational Psychiatry, 9(1), 1-7.
  16. Mancuso, S. G. (2016). Body image inflexibility mediates the relationship between body image evaluation and maladaptive body image coping strategies. Body Image, 16(1), 28-31.
  17. Mancuso, S. G., Knoesen, N. P., & Castle, D. J. (2010). Delusional versus nondelusional body dysmorphic disorder. Comprehensive Psychiatry, 51(2), 177-182.
  18. Mancuso, S. G., Knoesen, N. P., & Castle, D. J. (2010). The Dysmorphic Concern Questionnaire: A screening measure for body dysmorphic disorder. Australian and New Zealand Journal of Psychiatry, 44(6), 535-542.
  19. Mancuso, S. G., Knoesen, N. P., Chamberlain, J. A., Cloninger, C. R., & Castle, D. J. (2009). The temperament and character profile of a body dysmorphic disorder outpatient sample. Personality and Mental Health, 3(4), 284-294.
  20. Mancuso, S. G., Morgan, V. A., Mitchell, P. B., Berk, M., Young, A., & Castle, D. J. (2015). A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: Results from the Second Australian national psychosis survey. Journal of Affective Disorders, 172, 30-37.
  21. Mancuso, S. G., Newton, J. R., Bosanac, P., Rossell, S. L., Nesci, J. B., & Castle, D. J. (2015). Classification of eating disorders: comparison of relative prevalence rates using DSM-IV and DSM-5 criteria. The British Journal of Psychiatry, 206(6), 519-520.
  22. Meiklejohn, H., Mostaid, M. S., Luza, S., Mancuso, S. G., Kang, D., Atherton, S., . . . Pantelis, C. (2019). Blood and brain protein levels of ubiquitin-conjugating enzyme E2K (UBE2K) are elevated in individuals with schizophrenia. Journal of Psychiatric Research, 113, 51-57.
  23. Miller, K., Mancuso, S., Tacey, M., Walterfang, M., Velakoulis, D., & Hitch, D. (2019). The capacity of the BATCH as a predictive tool for discharge planning for people with neuropsychiatric disorders. Australian Occupational Therapy Journal, 66(2), 193-200.
  24. Moore, E., Mancuso, S. G., Slade, T., Galletly, C., & Castle, D. J. (2012). The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis. Australian & New Zealand Journal of Psychiatry, 46(9), 864-878.
  25. Mostaid, M., Mancuso, S., Liu, C., Sundram, S., Pantelis, C., Everall, I., & Bousman, C. (2017). Meta-analysis reveals associations between genetic variation in the 5′ and 3′ regions of Neuregulin-1 and schizophrenia. Translational Psychiatry, 7(1), e1004-e1004.
  26. Murnane, A., Thompson, K., Mancuso, S. G., Lewin, J., & Orme, L. M. (2019). Exploring the effect of exercise physiology intervention among adolescent and young adults diagnosed with cancer. Rehabilitation Oncology, 37(2), 55-63.
  27. Newton, J., Bosanac, P., Mancuso, S., & Castle, D. (2013). Bridging the gap: does a specialist eating disorder service, aimed at developing a continuum of community care, make a difference? Australasian Psychiatry, 21(4), 365-370.
  28. O’Brien, C. L., Ski, C. F., Thompson, D. R., Moore, G., Mancuso, S., Jenkins, A., . . . Knowles, S. R. (2016). The Mental Health in Diabetes Service (MINDS) to enhance psychosocial health: study protocol for a randomized controlled trial. Trials, 17(1), 444.
  29. Phillips, B., Moulding, R., Kyrios, M., Nedeljkovic, M., & Mancuso, S. (2011). The relationship between body dysmorphic disorder symptoms and self‐construals. Clinical Psychologist, 15(1), 10-16.
  30. Saini, S. M., Mancuso, S., Mostaid, M. S., Liu, C., Pantelis, C., Everall, I., & Bousman, C. (2017). Meta-analysis supports GWAS-implicated link between GRM3 and schizophrenia risk. Translational Psychiatry, 7(8), e1196-e1196.
  31. Sankaranarayanan, A., Mancuso, S., & Castle, D. (2014). Smoking and suicidality in patients with a psychotic disorder. Psychiatry Research, 215(3), 634-640.
  32. Sankaranarayanan, A., Mancuso, S., Wilding, H., Ghuloum, S., & Castle, D. (2015). Smoking, suicidality and psychosis: a systematic meta-analysis. PloS one, 10(9), e0138147.
  33. Stolk, Y., Sevar, K., Tran, N., Mancuso, S. G., Chopra, P., & Castle, D. (2015). A comparative study of the economic and social functioning of Vietnamese-Australians with low English proficiency living with psychotic illness. International Journal of Social Psychiatry, 61(4), 319-329.
  34. Wannan, C. M., Cropley, V. L., Chakravarty, M. M., Van Rheenen, T. E., Mancuso, S., Bousman, C., . . . Bartholomeusz, C. F. (2019). Hippocampal subfields and visuospatial associative memory across stages of schizophrenia-spectrum disorder. Psychological Medicine, 49(14), 2452-2462.